EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The case for homebrew AI in diagnostic pathology

Julien Calderaro, Helen Morement, Frédérique Penault-Llorca, Stephen Gilbert, Jakob Nikolas Kather

The Journal of Pathology · 2025

DOI: 10.1002/path.6438 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Pathology, 2025. Verfasst von Julien Calderaro und 4 weiteren Autor:innen. Beteiligte Einrichtung: Département de Pathologie, Assistance Publique Hôpitaux de Paris, Groupe Hospitalier Henri Mondor, Créteil, France. Hauptthemen laut MEDLINE: Artificial Intelligence, Image Interpretation, Computer-Assisted, Pathology, Clinical. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Artificial intelligence (AI) methods for digital pathology have tremendous potential to improve cancer diagnostics, biomarkers, and ultimately patient care. These AI methods, if marketed and sold, require authorisation or clearance as in vitro diagnostic (IVD) devices by regulatory bodies like the Food and Drug Administration (FDA) in the USA or Notified Bodies in the European Union (EU). Many AI tools for digital pathology are unlikely to be commercially viable and taken up by commercial entities ready to navigate these complex and costly processes. However, a longstanding quality framework already exists that allows for lab‐developed tests, colloquially known as ‘homebrew’ tests, that are locally validated and performed under the responsibility and oversight of the pathologist. Here we argue for advancing homebrew AI systems within this existing framework to enhance patients' access to supportive digital diagnostic tools. We outline how homebrew AI models are currently permitted under regulatory provisions in the USA and the European Union, how a new US FDA rule may effectively regulate them out of existence, and propose steps to facilitate the safe and effective integration of homebrew AI models in pathology practice. © 2025 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Artificial IntelligenceImage Interpretation, Computer-AssistedPathology, ClinicalHumansEuropean UnionUnited StatesUnited States Food and Drug Administration

Stichwörter der Autor:innen

artificial intelligencedeep learninghomebrewlaboratory‐derived testpathologywhole‐slide image

Autor:innen und Institutionen

  • Département de Pathologie, Assistance Publique Hôpitaux de Paris, Groupe Hospitalier Henri Mondor, Créteil, France.
  • MINT-HEP Mondor Integrative Hepatology, Institut Mondor de Recherche Biomédicale, Université Paris Est Créteil, Créteil, France.
  • AMMF-The Cholangiocarcinoma Charity, Chelmsford, UK.
  • INSERM U1240, [Molecular Imaging & Theragnostic Strategies (IMOST)], University Clermont Auvergne, Clermont-Ferrand, France.
  • Department of Pathology, Centre Jean PERRIN, Clermont-Ferrand, France.
  • Else Kröner Fresenius Center for Digital Health, TUD Dresden University of Technology, Dresden, Germany.

Zitieren

APA

Calderaro, J., Morement, H., Penault-Llorca, F., Gilbert, S., & Kather, J. N. (2025). The case for homebrew AI in diagnostic pathology. The Journal of Pathology. https://doi.org/10.1002/path.6438

Vancouver

Calderaro J, Morement H, Penault-Llorca F, Gilbert S, Kather JN. The case for homebrew AI in diagnostic pathology. The Journal of Pathology. 2025. doi:10.1002/path.6438

BibTeX
@article{Calderaro2025,
  author = {Calderaro, Julien and Morement, Helen and Penault-Llorca, Frédérique and Gilbert, Stephen and Kather, Jakob Nikolas},
  title = {The case for homebrew AI in diagnostic pathology},
  journal = {The Journal of Pathology},
  year = {2025},
  doi = {10.1002/path.6438}
}
Kostenlos starten →